Dashboard
Manage Tickers

AURA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

recap-aura-biosciences-q4-earnings
Recap: Aura Biosciences Q4 Earnings
03/27/2024 13:25:06

aura-biosciences-inc-files-for-mixed-shelf-offering-of-up-to-350m
Aura Biosciences Inc Files For Mixed Shelf...
03/27/2024 12:18:49

aura-biosciences-cash-and-cash-equivalents-and-marketable-securities-totaling-2262m-is-expected-to-provide-cash-runway-into-2h-2026
Aura Biosciences' Cash And Cash Equivalent...
03/27/2024 11:15:25

aura-biosciences-fy-2023-eps-193-misses-182-estimate
Aura Biosciences FY 2023 EPS $(1.93) Misse...
03/27/2024 11:14:26

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate of $(...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/09/2024 13:06:02

btig-maintains-buy-on-aura-biosciences-lowers-price-target-to-21
BTIG Maintains Buy on Aura Biosciences, Lo...
12/08/2023 17:43:47

BTIG analyst Robert Hazlett maintains Aura Biosciences (NASDAQ:AURA) with a Buy and lowers the price target from $38 to $21.

aura-biosciences-has-dosed-the-first-patient-in-the-global-phase-3-compass-trial-evaluating-the-safety-and-efficacy-of-belzupacap-sarotalocan-bel-sar-for-the-first-line-treatment-of-early-stage-choroidal-melanoma
Aura Biosciences Has Dosed The First Patie...
12/07/2023 13:04:18

jmp-securities-maintains-market-outperform-on-aura-biosciences-lowers-price-target-to-19
JMP Securities Maintains Market Outperform...
11/10/2023 19:40:33

JMP Securities analyst Jonathan Wolleben maintains Aura Biosciences (NASDAQ:AURA) with a Market Outperform and lowers the pr...

over-13m-bet-on-this-energy-stock-check-out-these-4-stocks-insiders-are-buying
Over $13M Bet On This Energy Stock? Check ...
11/10/2023 13:52:06

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

aura-biosciences-q3-eps-048-beats-052-estimate
Aura Biosciences Q3 EPS $(0.48) Beats $(0....
11/09/2023 22:33:37

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0....

why-aura-biosciences-stock-hit-a-new-52-week-low-today
Why Aura Biosciences Stock Hit A New 52-We...
11/07/2023 20:17:44

Aura Biosciences Inc (NASDAQ: AURA) shares are trading lower by 34.7% to $7.18 Tuesday afternoon after the company announced pr...

why-sanmina-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Sanmina Shares Are Trading Lower By Ar...
11/07/2023 18:10:11

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spe...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
11/07/2023 17:31:21

why-alteryx-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket
Why Alteryx Shares Are Trading Higher By A...
11/07/2023 13:28:51

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reporte...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
11/07/2023 13:06:23

sanmina-adtran-ameresco-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Sanmina, Adtran, Ameresco And Other Big St...
11/07/2023 11:15:51

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market tradin...

aura-biosciences-prices-public-offering-of-11m-common-shares-at-9share
Aura Biosciences Prices Public Offering Of...
11/07/2023 07:05:04

aura-biosciences-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed
Aura Biosciences Announces Proposed Public...
11/06/2023 22:43:48

Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
11/06/2023 21:31:02

aura-biosciences-receives-fda-agreement-under-special-protocol-assessment-for-compass-phase-3-clinical-trial-of-belzupacap-sarotalocan-in-early-stage-choroidal-melanoma
Aura Biosciences Receives FDA Agreement Un...
11/06/2023 20:01:36

Positive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing Phase 2 Clinical Trial with S...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION